Breast Cancer Clinical Trial
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Summary
The study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation therapy and to foster receptivity and informed decision-making around cancer clinical trial participation.
Full Description
Research suggests that utilization of audiovisual educational interventions may help to address health literacy and language barriers as well as suboptimal outcomes and trial enrollment in minority and/or non-English speaking patients. However, this has yet to be demonstrated in the radiation oncology setting, in which educational material is limited to written brochures for non-English speaking patients. Herein, the investigators propose to develop and implement a targeted linguistically and culturally appropriate audiovisual intervention (AVI) for Latinx/Spanish-speaking (SS) patients undergoing curative radiotherapy (RT). Our overall objective is to demonstrate benefit of AVI on RT knowledge, adherence, satisfaction and cancer trial perceptivity and enrollment in Latinx/SS patients. The investigators also aim to identify patient-specific and modifiable system-level factors predictive of quality RT delivery and clinical trial accrual to instruct future demographic-segmentation strategies focused on reducing outcomes disparities within radiation oncology.
Eligibility Criteria
Pilot Phase Inclusion Criteria:
Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
Currently undergoing treatment for breast or prostate cancer, or recently been treated
Pilot Phase Exclusion Criteria:
Patient with bilateral deafness and/or blindness
Patient with psychosis and/or dementia
Main Study Inclusion Criteria:
Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
Patients with non-metastatic prostate or breast cancer
Histopathologically proven diagnosis of prostate or breast cancer
History and physical examination within 28 days prior to enrollment
Karnofsky performance status 70 or greater
For women of childbearing potential, pregnancy testing to be performed in accordance to institutional guidelines
Plan to receive definitive, curative radiation. Patients planning to receive curative RT after upcoming adjuvant chemotherapy or induction hormonal therapy may enroll at reconsult "follow-up" visit.
Consultation visit must be performed with a certified interpreter
Main Study Exclusion Criteria:
Patient with bilateral deafness and/or blindness
Patient with psychosis and/or dementia
Clinical or radiological evidence of metastatic disease
Prior participation in cancer patient education trial
Prior RT
RT for sites other than breast or prostate
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10032, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.